Filter

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Marco Nardi x
Clear All Modify Search
Elena Sabini Endocrinology Units, Department of Clinical and Experimental Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy

Search for other papers by Elena Sabini in
Google Scholar
PubMed Close
,
Marenza Leo Endocrinology Units, Department of Clinical and Experimental Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy

Search for other papers by Marenza Leo in
Google Scholar
PubMed Close
,
Barbara Mazzi Endocrinology Units, Department of Clinical and Experimental Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy

Search for other papers by Barbara Mazzi in
Google Scholar
PubMed Close
,
Roberto Rocchi Endocrinology Units, Department of Clinical and Experimental Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy

Search for other papers by Roberto Rocchi in
Google Scholar
PubMed Close
,
Francesco Latrofa Endocrinology Units, Department of Clinical and Experimental Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy

Search for other papers by Francesco Latrofa in
Google Scholar
PubMed Close
,
Marco Nardi Ophthalmopathy Unit I, Department of Surgical, Medical and Molecular Pathology, University of Pisa and University Hospital of Pisa, Pisa, Italy

Search for other papers by Marco Nardi in
Google Scholar
PubMed Close
,
Paolo Vitti Endocrinology Units, Department of Clinical and Experimental Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy

Search for other papers by Paolo Vitti in
Google Scholar
PubMed Close
,
Claudio Marcocci Endocrinology Units, Department of Clinical and Experimental Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy

Search for other papers by Claudio Marcocci in
Google Scholar
PubMed Close
, and
Michele Marinò Endocrinology Units, Department of Clinical and Experimental Medicine, University of Pisa and University Hospital of Pisa, Pisa, Italy

Search for other papers by Michele Marinò in
Google Scholar
PubMed Close

Objectives: There is a general belief that Graves’ orbitopathy (GO) is a “chronic” disease, namely that patients’ eyes do not return to how they were before GO appeared. Here, we investigate this issue from both the patient’s and the physician’s point of view. Study Design: We studied the disappearance of GO, regardless of treatment, in all consecutive patients with a GO history of at least 10 years who came for a follow-up visit over a period of 5 years. Patients underwent an ophthalmological examination and were asked to answer a questionnaire on self-perception related to GO. Results: We studied 99 consecutive patients with a GO duration ≥10 years. Between the first and the last observation, patients received several types of treatment for their thyroid disease and/or for GO. At the end of follow-up, GO was considered disappeared based on objective criteria in 8 patients (∼8%) and based on subjective criteria in 24 patients (∼24%). When we considered both subjective and objective criteria, only 2 patients (∼2%) had all criteria fulfilled and could be considered as GO-free. Conclusions: GO is a chronic disease in the vast majority of patients. Even after a very long time since its onset, complete disappearance is rare, although a minority of patients believe they do not have GO anymore and an even lower proportion do not have relevant GO signs. Our findings have obvious implications in patient management and counseling.

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000477803
Volume/Issue:
Volume 6: Issue 5
Free access